caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1073629986

Raza JafryM.D.

HospitalistFort Worth, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 150005
Hospital
CCN 450039
Hospital
REFERRAL NETWORK

Where Raza Jafry's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
TARRANT COUNTY HOSPITAL DISTRICT811,197
John Meehan
Diagnostic Radiology · Fort Worth, TX
1444
PAWGAN, ARTHUR1435
Walworth Burge
Diagnostic Radiology · Fort Worth, TX
1447
NPI 15180948791344
Jyotsna Donepudi
Interventional Radiology · Fort Worth, TX
1128
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
115
Unique beneficiaries
—
Total services
175
Distinct HCPCS
4
Medicare payment
$12K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,047 Hospitalist providers in TX — bottom quintile (cohort median 457).
PRESCRIBING · PART D · 2024
Total Rx claims
1,332
Beneficiaries
—
Total drug cost
$2.9M
Distinct drugs
15
Brand share
50.3%
Top prescribed drugs
Hydroxychloroquine Sulfate440 claims
Etanercept176 claims
Methotrexate Sodium128 claims
Abatacept114 claims
Adalimumab91 claims
QUALITY · MIPS · 2024
Final MIPS score
96.4
Quality
80.4
Cost
78.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.90%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.